Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Recruiting now
Conditions studied: Alcoholic Hepatitis, Alcohol-related Liver Disease
In brief
This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At each of these visits, participants will undergo a HepQuant DuO test and other standard tests. In addition, the study team will ask about a participant's alcohol use, symptoms, and quality of life.
Key facts
- Study ID
- NCT07060547
- Run by
- HepQuant, LLC
- People needed
- 40
- Starts
- 2025-06-10
- Expected to finish
- 2032-03-01
- Last updated by the study team
- 2025-07-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- adult with a clinical diagnosis of liver disease due to alcohol who have acute hepatic decompensation.
- adult with a combined clinical diagnosis of alcohol-related liver disease (ALD) and nonalcoholic steatohepatitis (NASH).
You may not qualify if…
- Clinical diagnosis of liver disease with an etiology other than alcohol liver disease unless it is a combined clinical diagnosis of ALD and NASH.
- patients with solid organ malignancy.
- patients with other disease affecting the liver including autoimmune, drug-related liver injury, hemochromatosis or Wilson's disease
- pregnancy
- under the age of 18
Where it is running
- Stanford University Dept. of Medicine -Gastroenterology & Hepatology — Redwood City, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.